Abstract
Parkinson's disease (PD), one of the most common neurodegenerative diseases, is a multifactorial disease caused by both genetic and environmental factors. Although most patients suffering from PD have a sporadic disease, several genetic causes have been identified in recent years, including α-synuclein, parkin, PINK1, dardarm (LRRK2), and DJ-1. DJ-1 deletions and point mutations have been found worldwide, and loss of functional protein was shown to cause autosomal recessive PD. Moreover, DJ-1 immunoreactive inclusions are found in other α-synucleopathies and tauopathies, indicating that different neurodegenerative diseases might share a common mechanism in which DJ-1 might play a key role. The function of DJ-1 is still unknown; however, it is associated with various cellular processes, including response to oxidative stress, cellular transformation, RNA-binding, androgen-receptor signaling, spermatogenesis, and fertilization. This article reviews the current knowledge on DJ-1, focusing on its importance in the pathogenesis of PD.
Similar content being viewed by others
References
Abou-Sleiman P. M., Healy D. G., and Wood N. W. (2004) Causes of Parkinson's disease: genetics of DJ-1. Cell Tissue Res. 318, 185–188.
Abou-Sleiman P. M., Healy D. G., Quinn N., Lees A. J., and Wood N. W. (2003) The role of pathogenic DJ-1 mutations in Parkinson's disease. Ann. Neurol. 54, 283–286.
Annesi G., Savettieri G., Pugliese P., D'Amelio M., Tarantino P., Ragonese P., et al. (2005) DJ-1 mutations and parkinsonism-dementia-amyo trophic lateral sclerosis complex. Ann Neurol. 58, 803–807.
Bader V., Ran Zhu X., Lubbert H., and Stichel C. C. (2005) Expression of DJ-1 in the adult mouse CNS. Brain Res. 1041, 102–111.
Bandyopadhyay S. and Cookson M. R. (2004) Evolutionary and functional relationships within the DJ-1 super-family. BMC Evol. Biol. 4, 6.
Bandopadhyay R., Kingsbury A. E., Cookson M. R., Reid A. R., Evans I. M., Hope A. D., et al. (2004) The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. Brain 127, 420–430.
Bandopadhyay R., Miller D. W., Kingsbury A. E., Jowett T. P., Kaleem M. M., Pittman A. M., et al. (2005) Development, characterisation and epitope mapping of novel monoclonal antibodies for DJ-1 (PARK7) protein. Neurosci. Lett. 383, 225–230.
Baulac S., La Voie M. J., Strahle J., Schlossmacher M. G., and Xia W. (2004) Dimerization of Parkinson's disease-causing DJ-1 and formation of high molecular weight complexes in human brain. Mol. Cell. Neurosci. 27, 236–246.
Blackinton J., Ahmad R., Miller D. W., van der Brug M. P., Canet-Aviles R. M., Hague S. M., et al. (2005) Effects of DJ-1 mutations and polymorphisms on protein stability andsubcellular localization. Brain Res. Mol. Brain Res. 134, 76–83.
Bonifati V., Oostra B. A., and Heutink P. (2004) Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson's disease. J. Mol. Med. 82, 163–174.
Bonifati V., Rizzu P., van Baren M. J., Schaap O., Breedveld G. J., Krieger E., et al. (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299, 256–259.
Canet-Aviles R. M., Wilson M. A., Miller D. W., Ahmad R., McLendon C., Bandyopadhyay S., et al. (2004) The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl. Acad. Sci. U. S. A. 101, 9103–9108.
Chen L., Cagniard B., Mathews T., Jones S., Koh H. C., Ding Y., et al. (2005) Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice. J. Biol. Chem. 280, 21,418–21,426.
Clark L. N., Afridi S., Mejia-Santana H., Harris J., Louis E. D., Cote L. J., et al. (2004) Analysis of an early-onset Parkinson's disease cohort for DJ-1 mutations. Mov. Disord. 19, 796–800.
Dawson T. M. and Dawson V. L. (2003) Molecular pathways of neurodegeneration in Parkinson's disease. Science 302, 819–822.
Dekker M. C., Eshuis S. A., Maguire R. P., Veenma-van der Duijn L., Pruim J., Snijders P. J., et al. (2004) PET neuroimaging and mutations in the DJ-1 gene. J. Neural Transm. 111, 1575–1581.
Forno L. S. (1996) Neuropathology of Parkinson's disease. J. Neuropathol. Exp. Neurol. 55, 259–272.
Gasser T., Müller-Myhsok B., Wszolek Z. K., et al. (1998) A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat. Genet. 18, 262–265.
Giasson B. I., Duda J. E., Murray I. V., Chen Q., Souza J. M., Hurtig H.I., et al. (2000) Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 290, 985–989.
Goldberg M. S., Pisani A., Haburcak M., Vortherms T. A., Kitada T., Costa C., et al. (2005) Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron 45, 489–496.
Good P. F., Hsu A., Werner P., Perl D. P., and Olanow C. W. (1998) Protein nitration in Parkinson's disease. J. Neuropathol. Exp. Neurol. 57, 338–342.
Hague S., Rogaeva E., Hernandez D., Gulick C., Singleton A., Hanson M., et al. (2003) Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation. Ann. Neurol. 54, 271–274.
Hampshire D. J., Roberts E., Crow Y., Bond J., Mubaidin A., Wriekat A. L., et al. (2001) Kufor-Rakeb syndrome, pallido-pyramidal generation with supranuclear upgaze paresis and dementia, maps to 1p36. J. Med. Genet. 38, 680–682.
Hedrich K., Djarmati A., Schafer N., Hering R., Wellenbrock C., Weiss P. H., et al. (2004a) DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease. Neurology 62, 389–394.
Hedrich K., Schafer N., Hering R., Hagenah J., Lanthaler A. J., Schwinger E., et al. (2004b) The R98Q variation in Dj-1 represents a rare polymorphism. Ann. Neurol. 55, 145.
Hicks A. A., Petursson H., Jonsson T., Stefansson H., Johannsdottir H. S., Sainz J., et al. (2002) A susceptibility gene for late-onset idiopathic Parkinson's disease. Ann. Neurol. 52, 549–555.
Hod Y. (2004) Differential control of apoptosis by DJ-1 in prostate benign and cancer cells. J. Cell. Biochem. 92, 1221–1233.
Hod Y., Pentyala S. N., Whyard T. C., and El-Maghrabi M. R. (1999) Identification and characterization of a novel protein that regulates RNA-protein interaction. J. Cell. Biochem. 72, 435–444.
Jin J., Meredith G. E., Chen L., Zhou Y., Xu J., Shie F. S., et al. (2005) Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease. Brain Res. Mol. Brain Res. 134, 119–138.
Kim R. H., Peters M., Jang Y., Shi W., Pintilie M., Fletcher G. C. et al. (2005a) DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 7, 263–273.
Kim R. H., Smith P. D., Aleyasin H., Hayley S., Mount M. P., Pownall S., et al. (2005b) Hypersensitivity of DI-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 102, 5215–5220.
Kinumi T., Kimata J., Taira T., Ariga H., and Niki E. (2004) Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical veinendothelial cells. Biochem. Biophys. Res. Commun. 317, 722–728.
Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., et al. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605–608.
Klein C., Djarmati A., Hedrich K., Schafer N., Scaglione C., Marchese R., et al. (2005) PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism. Eur. J. Hum. Genet. 13, 1086–1093.
Kotaria N., Hinz U., Zechel S., von Bohlen U., and Halbach O. (2005) Localization of DJ-1 protein in the murine brain. Cell Tissue Res. 322, 503–507.
Le W. D., Xu P., Jankovic J., Jiang H., Appel S. H., Smith R. G., and Vassilatis D. K. (2003). Mutations in NR4A2 associated with familial Parkinson disease. Nat. Genet 33, 85–89.
Lee S. J., Kim S. J., Kim I. K., Ko J., Jeong C. S., Kim G. H., et al. (2003) Crystal structures of human DJ-1 and Escherichia coli Hsp31, which share an evolutionarily conserved domain. J. Biol. Chem. 278, 44,552–44,559.
Le Naour F., Misek D. E., Krause M. C., Deneux L., Giordano T. J., Scholl S., and Hanash S. M. (2001) Proteomics-based identification of RS/DJ-1 as a novel ciculating tumor antigen in breast cancer. Clin. Cancer Res. 7, 3328–3335.
Leroy E., Boyer R., Auburger G., Leube B., Ulm G., Mezey E., et al. (1998) The ubiquitin pathway in Parkinson's disease. Nature 395, 451–452.
Lockhart P. J., Lincoln S., Hulihan M., Kachergus J., Wilkes K., Bisceglio G., et al. (2004) DJ-1 mutations are a rare cause of recessively inherited early onset parkinsonism mediated by loss of protein function. J. Med. Genet. 41, e22.
Maraganore D. M., Hernandez D. G., Singleton A. B., Farrer M. J., McDonnell S. K., Hutton M. L., et al. (2001) Case-control study of the extended tau gene haplotype in Parkinson's disease. Ann. Neurol. 50, 658–661.
Martinat C., Shendelman S., Jonason A., Leete T., Beal M. F., Yang L., et al. (2004) Senstivity to oxidative stress in DJ-1-deficient dopamine neurons: an ES-derived cell model of primary parkinsonism. PLos Biol. 2, e327.
Marx F. P., Holzmann C., Strauss K. M., Li L., Eberhardt O., Gerhardt E., et al. (2003) Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease. Hum. Mol. Genet. 12, 1223–1231.
McNaught K. S., Belizaire R., Jenner P., Olanow C. W., and Isacson O. (2002) Selective loss of 20Sproteasome alphasubunits in the substantia nigra pars compacta in Parkinson's disease. Neurosci. Lett. 326, 155–158.
Menzies F. M., Yenisetti S. C., and Min K. T. (2005) Roles of Drosophila DJ-1 in survival of dopaminergic neurons and oxidative stress. Curr. Biol. 15, 1578–1582.
Meulener M., Whitworth A. J., Armstrong-Gold C. E., Rizzu P., Heutink P., Wes P. D., et al. (2005a) Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease. Curr. Biol. 15, 1572–1577.
Meulener M. C., Graves C. L., Sampathu D. M., Armstrong-Gold C. E., Bonini N. M., and Giasson B. I. (2005b) DJ-1 is present in a large molecular complex in human brain tissue and interacts with alpha-synuclein. J. Neurochem. 93, 1524–1532.
Mitsumoto A. and Nakagawa Y. (2001) DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin. Free Radic. Res. 35, 885–893.
Mitsumoto A., Nakagawa Y., Takeuchi A., Okawa K., Iwamatsu A., and Takanezawa Y. (2001) Oxidized forms of peroxiredoxins and DJ-1 on two-dimensional gels increased in response to sublethal levels of paraquat. Free Radic. Res. 35, 301–310.
Moore D. J., Zhang L., Dawson T. M., and Dawson V. L. (2003) An missense mutation (L166P) in DJ-1, linked to familial Parkinson's disease, confers reduced protein stability and impairs homo-oligomerization. J. Neurochem. 87, 1558–1567.
Moore D. J., Zhang L., Troncoso J., Lee M. K., Hattori N., Mizuno Y., et al. (2005) Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress. Hum. Mol. Genet. 14, 71–84.
Nagakubo D., Taira T., Kitaura H., Ikeda M., Tamai K., Iguchi-Ariga S. M., and Ariga H. (1997) DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem. Biophys. Res. Commun. 231, 509–513.
Neumann M., Muller V., Gorner K., Kretzschmar H. A., Haass C., and Kahle P. J. (2004) Pathological properties of the Parkinson's disease-associated protein DJ-1 in alpha-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick's disease. Acta Neuropathol. (Berl.) 107, 489–496.
Okada M., Matsumoto K., Niki T., Taira T., Iguchi-Ariga S. M., and Ariga H. (2002) DJ-1, a target protein for an endocrine disrupter, participates in the fertilization in mice. Biol. Pharm. Bull. 25, 853–856.
Olzmann J. A., Brown K., Wilkinson K. D., Rees H. D., Huai Q., Ke H., et al. (2004) Familial Parkinson's disease-associated L166P mutation disrupts DJ-1 protein folding and function. J. Biol. Chem. 279, 8506–8515.
Paisan-Ruiz C., Jain S., Evans E. W., Gilks W. P., Simon J., van der Brug M., et al. (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44, 595–600.
Pankratz N., Nichols W. C., Uniacke S. K., Halter C., Rudolph A., Schults C., et al. (2003) Significant linkage of Parkinson disease to chromosome 2q36–37. Am. J. Hum. Genet. 72, 1053–1057.
Park J., Kim S. Y., Cha G. H., Lee S. B., Kim S., and Chung J. (2005) Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction. Gene 361C, 133–139.
Pollanen M. S., Dickson D. W., and Bergeron C. (1993) Pathology and biology of the Lewy body. J. Neuropathol. Exp. Neurol. 52, 183–191.
Polymeropoulos M. H., Lavedan C., Leroy E., Ide S. E., Dehejia A., Dutra A., et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045–2047.
Rizzu P., Hinkle D. A., Zhukareva V., Bonifati V., Severijnen L. A., Martinez D., et al. (2004) DJ-1 colocalizes with tau inclusions: a link between parkinsonism and dementia. Ann. Neurol. 55, 113–118.
Sekito A., Taira T., Niki T., Iguchi-Ariga S. M., and Ariga H. (2005) Stimulation of transforming activity of DJ-1 by Abstrakt, a DJ-1-binding protein. Int. J. Oncol. 26, 685–689.
Shang H., Lang D., Jean-Marc B., and Kaelin-Lang A. (2004) Localization of DJ-1 mRNA in the mouse brain. Neurosci. Lett. 367, 273–277.
Shendelman S., Jonason A., Martinat C., Leete T., and Abeliovich A. (2004) DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation. PLoS Biol. 2, e362.
Shinbo Y., Taira T., Niki T., Iguchi-Ariga S. M., and Ariga H. (2005) DJ-1 restores p53 transcription activity inhibited by Topors/p53BP3. Int. J. Oncol. 26, 641–648.
Singleton A. B., Farrer M., Johnson J., Singleton A. B., Farrer M., Johnson J., et al. (2003) α-Synuclein locus triplication causes Parkinson's disease. Science 302, 841–844.
Spillantini M. G., Crowther R. A., Jakes R., Hasegawa M., and Goedert M. (1995) Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. U. S. A. 95, 6469–6473.
Taira T., Iguchi-Ariga S. M., and Ariga H. (2004a) Co-localization with DJ-1 is essential for the androgen receptor to exert its transcription activity that has been impaired by androgen antagonists. Biol. Pharm. Bull. 27, 574–577.
Taira T., Saito Y., Niki T., Iguchi-Ariga S. M., Takahashi K., and Ariga H. (2004b) DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep. 5, 213–218.
Taira T., Takahashi K., Kitagawa R., Iguchi-Ariga S. M., and Ariga H. (2001) Molecular cloning of human and mouse DJ-1 genes and identification of Sp1-dependent activation of the human DJ-1 promoter. Gene 263, 285–292.
Takahashi K., Taira T., Niki T., Seino C., Iguchi-Ariga S. M., and Ariga H. (2001) DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor. J. Biol. Chem. 276, 37,556–37,563.
Takahashi-Niki K., Niki T., Taira T., Iguchi-Ariga S. M., and Ariga H. (2004) Reduced anti-oxidative stress activities of DJ-1 mutants found in Parkinson's disease patients. Biochem. Biophys. Res. Commun. 320, 389–397.
Valente E. M., Abou-Steiman P. M., Caputo V., et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158–1160.
van Duijin C. M., Dekker M. C., Bonifati V., Galjaard R. J., Houwing-Duistermaat J. J., Snijders P. J., et al. (2001) Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. Am. J. Hum. Genet. 69, 629–634.
Wilson M. A., Collins J. L., Hod Y., Ringe D., and Petsko G. A. (2003) The 1.1-A resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 100, 9256–9261.
Yokota T., Sugawara K., Ito K., Takahashi R., Ariga H., and Mizusawa H. (2003) Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. Biochem. Biophys. Res. Commun. 312, 1342–1348.
Yoshida K., Sato Y., Yoshijke M., Nozawa S., Ariga H., and Iwamoto T. (2003) Immunocy tochemical localization of DJ-1 in human male reproductive tissue. Mol. Reprod. Dev. 66, 391–397.
Zhang L., Shimoji M., Thomas B., Moore D. J., Yu S. W., Marupudi N. I., et al. (2005) Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis. Hum. Mol. Genet. 14, 2063–2073.
Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., et al. (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601–607.
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article is available at http://dx.doi.org/10.1385/JMN:31:03:307.
Rights and permissions
About this article
Cite this article
Lev, N., Roncevich, D., Ickowicz, D. et al. Role of DJ-1 in Parkinson's disease. J Mol Neurosci 29, 215–225 (2006). https://doi.org/10.1385/JMN:29:3:215
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1385/JMN:29:3:215